Financials data is unavailable for this security.
View more
Year on year Kazia Therapeutics Ltd grew revenues 979.43% from 2.09k to 22.56k while net income improved from a loss of 25.01m to a smaller loss of 20.47m.
Gross margin | -- |
---|---|
Net profit margin | -90,714.45% |
Operating margin | -91,918.53% |
Return on assets | -63.98% |
---|---|
Return on equity | -134.97% |
Return on investment | -82.39% |
More ▼
Cash flow in AUDView more
In 2023, cash reserves at Kazia Therapeutics Ltd fell by 2.12m. Cash Flow from Financing totalled 12.97m or 57,500.00% of revenues. In addition the company used 15.16m for operations while cash from investing was breakeven.
Cash flow per share | -- |
---|---|
Price/Cash flow per share | -- |
Book value per share | 34.41 |
---|---|
Tangible book value per share | -14.90 |
More ▼
Balance sheet in AUDView more
Current ratio | 1.42 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.1491 |
---|---|
Total debt/total capital | 0.1297 |
More ▼